Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic
José Alexandre S. Crippa, Antônio Waldo Zuardi, Francisco Silveira Guimarães, et al.
JAMA Network Open (2021) Vol. 4, Iss. 8, pp. e2120603-e2120603
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
Jiangling Peng, Mingjie Fan, Chelsea An, et al.
Basic & Clinical Pharmacology & Toxicology (2022) Vol. 130, Iss. 4, pp. 439-456
Open Access | Times Cited: 180
Remote work burnout, professional job stress, and employee emotional exhaustion during the COVID-19 pandemic
Alina Costin, Alina Felicia Roman, Raluca-Ștefania Balica
Frontiers in Psychology (2023) Vol. 14
Open Access | Times Cited: 48
Addressing Health Care Workers’ Mental Health: A Systematic Review of Evidence-Based Interventions and Current Resources
W. Kent Anger, Jennifer K. Dimoff, Lindsey Alley
American Journal of Public Health (2024) Vol. 114, Iss. S2, pp. 213-226
Open Access | Times Cited: 16
The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence
Jonathon C. Arnold, Danielle McCartney, Anastasia Suraev, et al.
Clinical and Translational Science (2022) Vol. 16, Iss. 1, pp. 10-30
Open Access | Times Cited: 54
Statement on safety of cannabidiol as a novel food: data gaps and uncertainties
Dominique Turck, Torsten Bohn, Jacqueline Castenmiller, et al.
EFSA Journal (2022) Vol. 20, Iss. 6
Open Access | Times Cited: 49
A biomedical knowledge graph-based method for drug–drug interactions prediction through combining local and global features with deep neural networks
Zhong-Hao Ren, Zhu‐Hong You, Chang-Qing Yu, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 5
Closed Access | Times Cited: 43
Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020–2022)
José Diogo R. Souza, Júlia Cozar Pacheco, Giordano Novak Rossi, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2598-2598
Open Access | Times Cited: 38
Cannabidiol‐associated hepatotoxicity: A systematic review and meta‐analysis
Lindsay A. Lo, April Christiansen, Lauren Eadie, et al.
Journal of Internal Medicine (2023) Vol. 293, Iss. 6, pp. 724-752
Open Access | Times Cited: 35
The therapeutic potential of purified cannabidiol
Saoirse E. O’Sullivan, Sanne Jensen, Gitte Nykjaer Nikolajsen, et al.
Journal of Cannabis Research (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 29
Dual cytoplasmic‐peroxisomal compartmentalization engineering and multiple metabolic engineering strategies for high yield non‐psychoactive cannabinoid in Saccharomyces cerevisiae
Yun‐kun Ding, Yuan Ning, Di Xin, et al.
Biotechnology Journal (2024) Vol. 19, Iss. 2
Closed Access | Times Cited: 11
Potential strategies for supporting mental health and mitigating the risk of burnout among healthcare professionals: insights from the COVID-19 pandemic
George Collett, Ania Korszun, Ajay Gupta
EClinicalMedicine (2024) Vol. 71, pp. 102562-102562
Open Access | Times Cited: 9
Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial
C. Kwee, Johanna M.P. Baas, Febe E. van der Flier, et al.
European Neuropsychopharmacology (2022) Vol. 59, pp. 58-67
Open Access | Times Cited: 30
Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions
Jeremy D. Henson, Luis Vitetta, Sean Hall
Inflammopharmacology (2022) Vol. 30, Iss. 4, pp. 1167-1178
Open Access | Times Cited: 30
Does Cannabidiol (CBD) in Food Supplements Pose a Serious Health Risk? Consequences of the European Food Safety Authority (EFSA) Clock Stop Regarding Novel Food Authorisation
Dirk W. Lachenmeier, Constanze Sproll, Stephan G. Walch
Psychoactives (2023) Vol. 2, Iss. 1, pp. 66-75
Open Access | Times Cited: 18
The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event
Lívia Maria Bolsoni, José Alexandre S. Crippa, Jaime E. C. Hallak, et al.
Brazilian Journal of Psychiatry (2022) Vol. 44, Iss. 3, pp. 298-307
Open Access | Times Cited: 24
Anxiolytic effects of endocannabinoid enhancing compounds: A systematic review and meta-analysis
C. Kwee, N.A. Leen, Rian C. Van der Kamp, et al.
European Neuropsychopharmacology (2023) Vol. 72, pp. 79-94
Open Access | Times Cited: 16
Update on Cannabidiol Clinical Toxicity and Adverse Effects: A Systematic Review
Graziella Madeo, Ashita Kapoor, Raffaele Giorgetti, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 11, pp. 2323-2342
Open Access | Times Cited: 14
Evaluation of the efficacy, safety, and pharmacokinetics of nanodispersible cannabidiol oral solution (150mg/ml) versus placebo in mild to moderate anxiety subjects: A double blind multicenter randomized clinical trial
Prasad Rao Gundugurti, Nagaraju Banda, Siva Sankara Rao Yadlapalli, et al.
Asian Journal of Psychiatry (2024) Vol. 97, pp. 104073-104073
Open Access | Times Cited: 5
Efficacy of Transcendental Meditation to Reduce Stress Among Health Care Workers
Sangeeta Joshi, An-Kwok Ian Wong, Amanda Brucker, et al.
JAMA Network Open (2022) Vol. 5, Iss. 9, pp. e2231917-e2231917
Open Access | Times Cited: 22
Cannabinoid treatments for anxiety: A systematic review and consideration of the impact of sleep disturbance
Andrea J. Narayan, Luke A. Downey, Brooke Manning, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 143, pp. 104941-104941
Closed Access | Times Cited: 21
Cannabidiol (CBD) in Rheumatic Diseases (Musculoskeletal Pain)
Kevin F. Boehnke, Winfried Häuser, Mary‐Ann Fitzcharles
Current Rheumatology Reports (2022) Vol. 24, Iss. 7, pp. 238-246
Open Access | Times Cited: 20
Resilience Improves the Quality of Life and Subjective Happiness of Physiotherapists during the COVID-19 Pandemic
Patricia Angeli da Silva Pigati, Renato Fraga Righetti, Victor Zuniga Dourado, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 14, pp. 8720-8720
Open Access | Times Cited: 19
Systematic Review and Meta-Analysis of Randomized Trials Testing Interventions to Reduce Physician Burnout
Alyson Haslam, Jordan Tuia, Sarah Miller, et al.
The American Journal of Medicine (2023) Vol. 137, Iss. 3, pp. 249-257.e1
Open Access | Times Cited: 12
Lessons from the pandemic: Relationship between patient visits and patient length of stay in California’s health system
David Cho, Yu Wang
Health Research Policy and Systems (2025) Vol. 23, Iss. 1
Open Access
The Burden of Comorbidity Between Mental and Physical Disorders: Identification, Management, and Treatment
M. Araújo, Michel Ferreira Cardia Haddad, Luiz Henrique Junqueira Dieckmann, et al.
(2025), pp. 3-32
Closed Access
Page 1 - Next Page

Scroll to top